The wide availability of affordable medicines can help countries achieve dramatic results with HIV/AIDS treatment programs. By using local generic production and competition to procure low-price quality drugs, the Brazilian National AIDS Program guarantees universal access to treatment for all Brazilians living with HIV/AIDS.
If FTAA had been in place when a presidential decree mandated universal access, it is doubtful that the program would ever have been possible, and Brazil may not have been able to achieve its spectacular success: 90,000 AIDS deaths averted, 60,000 AIDS cases prevented, and 358,000 AIDS-related hospitalizations avoided between 1996 and 2002, leading to government savings of more than US$2 billion during the same period.12 AIDS activists in Brazil are concerned about the negative impact of the US proposals on intellectual property in the FTAA.
© Mauro Siqueira
Click image for large view
On World AIDS Day, Brazilian AIDS activists celebrate the 90,000 deaths avoided through the country's ARV program.
12 - Paulo R. Teixeira, Marco Antonio Vitoria, Jhoney Barcarolo. "The Brazilian Experience in Providing Universal Access to Antiretroviral Therapy." In eds. J.P. Moati et. al., Economics of AIDS and Access to HIV/AIDS Care in Developing Countries. Issues and Challenges. Paris: ANRS/National Agency for AIDS Research, 2003. 80.